Hostname: page-component-cb9f654ff-lqqdg Total loading time: 0 Render date: 2025-08-29T19:13:16.565Z Has data issue: false hasContentIssue false

F.4 Risk factors for 30-day postoperative infection in pediatric ventricular shunts for hydrocephalus

Published online by Cambridge University Press:  10 July 2025

IE Harmsen
Affiliation:
(Edmonton)*
V Chan
Affiliation:
(Los Angeles)
G Shumilak
Affiliation:
(Saskatoon)
CA Elliott
Affiliation:
(Edmonton)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Ventricular shunt infections lead to significant morbidity and mortality. This study aimed to identify risk factors for 30-day postoperative infection outcomes of ventricular shunts for pediatric hydrocephalus. Methods: A retrospective cohort study using the National Surgical Quality Improvement Program (NSQIP) Pediatric database for years 2016-2021 was conducted. Patients under 18 years undergoing ventricular shunt surgery were included. The primary outcome was 30-day postoperative shunt infection. A multivariable logistic regression analysis of fourteen prognostic variables was performed. Results: A total of 10,878 patients (mean age 3.1 years, 44.2% female) were included. The 30-day postoperative shunt infection rate was 3.7%. Infection risk increased with nutritional support, longer operating room duration, and congenital hydrocephalus. Risk decreased with increasing age, intraoperative intraventricular antibiotics, and first-time shunt placement. Variables not significantly affecting infection risk included sex, BMI, ostomy, tracheostomy, neuromuscular disease, structural pulmonary/airway abnormality, steroid use, antibiotic-impregnated shunts, and endoscopic catheter placement. Conclusions: Postoperative shunt infections in pediatric patients are influenced by both modifiable and non-modifiable factors. Identifying and addressing modifiable risks can significantly reduce infection rates, minimize the need for surgical revisions, and enhance therapeutic outcomes and overall quality of life.

Information

Type
Abstracts
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation